Company intelligence / Profile preview

Celera

Alameda, California, United Statesceleratechnologies.com ↗

Ownership: Private
Employees: ~500
Development stage: Commercial

Overview

Celera was a pioneering genomics company best known for its role in sequencing the human genome using shotgun sequencing. It later shifted focus to developing and commercializing molecular diagnostic products and personalized disease management services. The company’s diagnostics business included tests for cardiovascular risk and other conditions. In 2011, it was acquired by Quest Diagnostics.

Therapeutic areas: OncologyCardiovascularGastroenterology
Modalities: Small moleculeDiagnostic testMolecular diagnostic product
Industry: Molecular Diagnostics

Partnerships

Abbott LaboratoriesMerck & Co.

Beyond the preview

Go deeper on Celera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celera.

Explore the full profile